Denali Therapeutics Inc. DNLI Business Segments — Other general and administrative expenses

Similar metrics at other companies

SNDXBiopharmaceutical Cancer Therapeutics — Other General And Administrative Expense

$5.14M+16.5%

BAXMedical Products & Therapies — Selling, general and administrative expenses

$290M+1.4%

ARESOther — General, administrative and other expenses

$2.56M+72.8%

ORIOther — General expenses, taxes and fees

$16.5M+17.9%

WSBCCorporate And Other — General And Administrative Expense

$370K+185%

CVSCorporate/ Other — Operating expenses, excluding other segment items

$674M+56.0%

Questions, answered.

What is Denali Therapeutics Inc.'s business segments — other general and administrative expenses?

Denali Therapeutics Inc. (DNLI) reported business segments — other general and administrative expenses of $10.95M in Q1 2026.

How has Denali Therapeutics Inc.'s business segments — other general and administrative expenses changed year-over-year?

Denali Therapeutics Inc.'s business segments — other general and administrative expenses increased by 3.1% year-over-year, from $10.62M to $10.95M.

What is the long-term trend for Denali Therapeutics Inc.'s business segments — other general and administrative expenses?

Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s business segments — other general and administrative expenses has grown at a 24.1% compound annual growth rate (CAGR), from $26.33M to $50.33M.

What does business segments — other general and administrative expenses mean?

Covers general corporate overhead costs such as professional fees, insurance, office facilities, and other administrative support services. These expenses reflect the operational burden of maintaining the corporate entity. Monitoring these costs helps assess the company's ability to control non-core spending as it scales.